-
1
-
-
0037153210
-
-
and references cited therein
-
Barreca M.L., Balzarini J., Chimirri A., De Clercq E., De Luca L., Holtje H.D., Holtje M., Monforte A.M., Montorte P., Pannecouque C., Rao A., and Zappala M. J. Med. Chem. 45 (2002) 5410 and references cited therein
-
(2002)
J. Med. Chem.
, vol.45
, pp. 5410
-
-
Barreca, M.L.1
Balzarini, J.2
Chimirri, A.3
De Clercq, E.4
De Luca, L.5
Holtje, H.D.6
Holtje, M.7
Monforte, A.M.8
Montorte, P.9
Pannecouque, C.10
Rao, A.11
Zappala, M.12
-
2
-
-
0026324187
-
-
Chimirri A., Grasso S., Monforte A.M., Monforte P., and Zappala M. Il Farmaco 46 (1991) 817
-
(1991)
Il Farmaco
, vol.46
, pp. 817
-
-
Chimirri, A.1
Grasso, S.2
Monforte, A.M.3
Monforte, P.4
Zappala, M.5
-
3
-
-
0025812546
-
-
Chimirri A., Grasso S., Montorte A.M., Monforte P., and Zappala M. Il Farmaco 46 (1991) 925
-
(1991)
Il Farmaco
, vol.46
, pp. 925
-
-
Chimirri, A.1
Grasso, S.2
Montorte, A.M.3
Monforte, P.4
Zappala, M.5
-
4
-
-
0032772910
-
-
and references cited therein
-
Chimirri A., Grasso S., Monforte P., Rao A., Zappala M., Monforte A.M., Pannecouque C., Witvrouw M., Balzarini J., and De Clercq E. Antiviral Chem. Chemother. 10 (1999) 211 and references cited therein
-
(1999)
Antiviral Chem. Chemother.
, vol.10
, pp. 211
-
-
Chimirri, A.1
Grasso, S.2
Monforte, P.3
Rao, A.4
Zappala, M.5
Monforte, A.M.6
Pannecouque, C.7
Witvrouw, M.8
Balzarini, J.9
De Clercq, E.10
-
7
-
-
0029081625
-
-
Benazzouz A., Boraud T., Dubedat P., Boireu A., Stutzmann J.M., and Gross C. Eur. J. Pharmacol. 284 (1995) 299
-
(1995)
Eur. J. Pharmacol.
, vol.284
, pp. 299
-
-
Benazzouz, A.1
Boraud, T.2
Dubedat, P.3
Boireu, A.4
Stutzmann, J.M.5
Gross, C.6
-
15
-
-
33644879165
-
-
Salehi P., Dabiri M., Zolfigol M.A., Otokesh S., and Baghbanzadeh M. Tetrahedron Lett. 47 (2006) 2557
-
(2006)
Tetrahedron Lett.
, vol.47
, pp. 2557
-
-
Salehi, P.1
Dabiri, M.2
Zolfigol, M.A.3
Otokesh, S.4
Baghbanzadeh, M.5
-
17
-
-
29944437429
-
-
Rao A., Chimirri A., Ferro S., Monforte A.M., Montorte P.M., and Zappala M. Arkivoc (2004) 147
-
(2004)
Arkivoc
, pp. 147
-
-
Rao, A.1
Chimirri, A.2
Ferro, S.3
Monforte, A.M.4
Montorte, P.M.5
Zappala, M.6
-
18
-
-
0242626227
-
-
note
-
4 and [MOEMIM]TFA have been synthesized according to the reported method, for example, Bonahote, P.; Dias, Ana-Paula; Papageorgiou, N.; Kalyansundram, K.; Graztel, M. Inorg. Chem. 1996, 35, 1168.
-
-
-
-
19
-
-
67650134086
-
-
note
-
254 plates) in petroleum ether-ethyl acetate (8:2) and visualization was accomplished in a iodine chamber/UV-light. After completion of the reaction, the contents were neutralized by 10% aqueous sodium bicarbonate solution and extraction was carried out with ethyl acetate (3 × 10 mL). The solvent was removed under reduced pressure (5 mm of Hg). The pasty mass, thus obtained, was extracted with diethyl ether (3 × 10 mL), dried over anhydrous sodium sulphate and ether was distilled. The product, so obtained, was purified by crystallization with ethanol/column chromatography (Merck Silica gel 60-120 mesh). The ionic liquid layer was washed with water (3 × 5 mL) and kept for 2 h at 80-85 °C under reduced pressure (5 mm of Hg). This ionic liquid was used in recycling.
-
-
-
-
20
-
-
67650152685
-
-
note
-
2OS
-
-
-
-
21
-
-
67650175445
-
-
note
-
Typical experimental procedure for synthesis of 1-aryl-1H,3H-thiazolo[3,4-a]benzimidazoles (2a-e): A mixture of 1,2-phenylenediamine (3 mmol), aromatic aldehyde (3 mmol), 2-mercaptoacetic acid (6 mmol) was taken in round bottom flask. The reaction was performed in the same way as described above.
-
-
-
-
22
-
-
67650166206
-
-
note
-
2S: C, 63.5; H, 4.00; N, 9.26. Found: C, 63.40; H, 3.91; N, 9.18.
-
-
-
|